TD Asset Management
HLVX

TD Asset Management’s HilleVax HLVX Stock Holding History

TD Asset Management’s Portfolio HLVX Stock Details HLVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-54,236
Closed -$784K – 1406
2024
Q2 		$784K Buy
54,236
+19,000
+54% +$261K ﹤0.01% 1204
2024
Q1 		$586K Buy
35,236
+16,708
+90% +$267K ﹤0.01% 1272
2023
Q4 		$297K Hold
18,528
– – ﹤0.01% 1340
2023
Q3 		$249K Hold
18,528
– – ﹤0.01% 1355
2023
Q2 		$318K Hold
18,528
– – ﹤0.01% 1331
2023
Q1 		$306K Hold
18,528
– – ﹤0.01% 1341
2022
Q4 		$310K Hold
18,528
– – ﹤0.01% 1353
2022
Q3 		$356K Hold
18,528
– – ﹤0.01% 1349
2022
Q2 		$203K Buy
+18,528
New +$220K ﹤0.01% 1385

Other funds holding HLVX

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
TPC
Takeda Pharmaceutical Company Tokyo, Japan $16.4M AUM 195.92% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

TD Asset Management's HLVX Position: Q3 2024 in Review

TD Asset Management sold out of HilleVax (HLVX) in Q3 2024, closing a stake of 54,236 shares — an estimated $784K sold.

TD Asset Management first reported a position in HLVX in Q2 2022 and held it in 9 quarters. The position peaked at $784K in Q2 2024. 79 funds tracked by Wall St. Rank hold HLVX as of Q3 2024.

  • TD Asset Management reported no remaining HilleVax position as of Q3 2024 after selling out during the quarter.
  • TD Asset Management sold 54,236 HilleVax shares in Q3 2024, an estimated $784K.
  • TD Asset Management first reported a position in HilleVax in Q2 2022 and held it in 9 quarters.
  • TD Asset Management's HilleVax position peaked at $784K in Q2 2024.
  • 79 funds tracked by Wall St. Rank held HilleVax as of Q3 2024.

Based on TD Asset Management's 13F filing for Q3 2024, filed 1 Nov 2024.